PTN Palatin Technologies Inc

Palatin Technologies Inc is a biopharmaceutical company engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical need and commercial potential.

As of 10/15/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  08/07/2001
Outstanding shares:  231,258,137
Average volume:  788,229
Market cap:   $98,631,595
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    696077403
ISIN:        US6960774031
Sedol:      2103781
Valuation   (See tab for details)
PE ratio:   -2.94
PB ratio:   1.98
PS ratio:   -522.98
Return on equity:   -67.66%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy